Oova acquires $10.3 million and introduces membership-based at-home fertility testing model

Oova acquires $10.3 million and introduces membership-based at-home fertility testing model

In vitro fertilization costs thousands of dollars, and infertility affects one in six people, prompting increased interest in women’s healthcare. Startups like Generation Prime, Flo, Future Family, Maven, and Mate Fertility are addressing this issue with recent acts of benefactions.

Oova, a women’s health and fertility startup, secured $10.3 million in Series A funding for its at-home fertility tracking method, showcasing its innovative approach to women’s health and fertility tracking. The company presents the Oova Membership, priced at $99 per month, which includes The Oova Kit and offers personalized support through the Oova Provider network of medical professionals and hormone experts.

Try the free Oova tracker app and take action.

Source: Oova

The Oova Kit, an at-home urine test, was launched in 2021 with $1.2 million in seed money. It measures luteinizing hormone and progesterone, providing personalized analytics and real-time action plans for women to determine their fertility and confirm ovulation.

Oova, an FDA-registered fertility tracking product, offers real-time syncing and sharing of results with doctors. Unlike other period and fertility tracking companies, Oova is HIPAA compliant and secures connections with clinic partners, ensuring secure connections.

Divaraniya reports a significant increase in adoption across consumer and medical channels, resulting in a high-quality dataset of treatments and hormone measurements. The ability to train algorithms using actual hormone data from thousands of women and intrapersonal data allows for a customized user experience, permitting a deeper understanding of individual women’s cycles.

A new round of financing for Spanx, led by Spero Ventures, involved US Fertility, Virgin Group, Jefferson Health, Connecticut Innovations, Hannah Bronfman, and Sara Blakely, raising $11.5 million. Oova revolutionizes hormonal health by making clinical-grade hormone monitoring convenient and affordable for daily use, empowering users to understand their loops, improve fertility outcomes, and manage symptoms. This innovative approach aims to improve fertility outcomes and manage symptoms.

Fertility is a passionate topic, as hormones control various stages of a woman’s life. Understanding traditional urban patterns can modify phases, impacting multiple trends.

About The Author

Leave a reply

Your email address will not be published. Required fields are marked *

Get Latest news in your inbox

Join our mailing list to receive the latest happenings from the startup world.

You have Successfully Subscribed!

Pin It on Pinterest

Share This